Jennifer Baird

Promoted from MSL → Senior MSL → Associate Director in recognition of strategic leadership and cross-functional impact.

• Lead the Scientific Collaboration Council (SCC), acting as the liaison between Global Medical Excellence and Field Medical to prioritize resource development, training, and evidence generation supporting early diagnosis and symptom recognition.
• Serve on CEO-prioritized sprint team to accelerate bronchiectasis diagnosis across the central region, identifying barriers in the patient diagnostic pathway and recommending strategic interventions to improve diagnostic efficiency.
• Collaborated with HEOR and Market Access to create quarterly payer policy insight reports, identifying system-level drivers of diagnostic delay that informed regional prioritization models.
• Developed and disseminated congress debrief frameworks (ATS, CTS, AMCP) capturing disease state, product, and competitive insights, presented to senior leadership to guide company strategy.
• Built relationships with influential pulmonologists and infectious disease specialists to enhance clinical suspicion in high-risk patient populations.
• Secured access to previously closed institutions (Intermountain Healthcare and University of Utah) through strategic KOL engagement, resulting in new center of excellence designations.
• Defined and tracked regional KPIs through MIRF insights, payer policy analysis, and site enrollment data; presented quarterly deep-dives to global medical and commercial leadership.
• Partnered with clinical affairs to identify and onboard 5+ new CRS and 2 new TPIP clinical trial sites, improving patient flow modeling and investigator relationships.
• Mentored 5 new MSLs on disease and product training, insight capture, and stakeholder mapping—building team capability to support NTM and Bronchiectasis franchise.
• Supported the Brinsupri speaker training, counseling physicians on data communication and diagnostic differentiation—directly feeding into channel-specific HCP content strategy.
• Influenced Arizona Infectious Disease Society to add NTM programming to 2024 agenda, increasing regional clinical suspicion among ID specialists.
• Recognized with 9 Inspire Awards and 3 Capri Awards for cross-functional collaboration, culture contribution, MOL/MSL liaison, and agile execution of virtual speaker training pivots.

• Led cross-functional development of the Target Product Profile (TPP) for the Joint Infection Panel, aligning R&D, regulatory, clinical affairs, and commercial teams around key performance targets (LoD, TAT, operator use) to de-risk development and accelerate launch readiness.
• Created go-to-market strategy for a novel multiplex PCR diagnostic test for prosthetic joint infections
• Developed and executed global brand plan, setting strategy and overseeing tactics across dependent departments to ensure alignment and timely delivery.
• Conducted market research and competitive landscape assessments, identifying refinement opportunities for product positioning to strengthen market competitiveness.
• Executed presence at national tradeshows (IDWeek, AAOS, ASM, ECCMID) to enhance product visibility and engage key stakeholders.

• Managed external relationships with key opinion leaders (KOLs) through facilitation of research collaborations, identification of speaker’s bureau targets, and clinical trial site support
• Served as the clinical expert by providing scientific and disease state information for Otsuka’s rare nephrological disorders portfolio to healthcare providers, managed care organizations, and hospital systems
• Represented the company as a professional speaker to support the launch of Jynarque (tolvaptan) for Autosomal Dominant Polycystic Disease through formal dinner programs targeting practicing nephrologists, academic researchers, and allied health professionals

• Acted as interim global product manager for Fabrazyme, developing competitive differentiation campaigns targeting geneticists and metabolic specialists.
• Conducted opportunity sizing and segmentation market research for early pipeline assets, guiding newborn screening and treatment adoption strategies.
• Developed product demand forecasting training module adopted globally across genetics portfolio, enhancing team capabilities in demand planning.

• Coordinated and delivered PPW 371A.A Introduction to the Biopharmaceutical Industry elective course, engaging students with practical insights into the biopharmaceutical sector
• Presented guest lectures for PSB 542 Fundamentals of the Biopharmaceutical Industry, enhancing student understanding of key industry concepts
• Guided fourth year PharmD experiential rotation students at Sanofi Genzyme, fostering their professional development through hands-on industry experience
• Lecture topics: Early Product Development, Drug Commercialization, Competitive Intelligence, Strategic and Tactical Marketing